Sonoma Orthopedic Products receives $12M in financing round

Written by Anuja Vaidya | December 17, 2014 | Print  |

Sonoma Orthopedic Products received $12 million in funding from First Analysis, according to a Reuters PE Hub report.

Sonoma Orthopedic Products focuses on developing and manufacturing orthopedic implants for the wrist, ankle and collarbone. The financing round is intended to allow the company to receive clearance from the U.S. Food and Drug Administration for its new ankle implant as well as launch it and scale it commercially.

 

First Analysis is a private growth-equity investor.

More articles on devices:

VEXIM's Masterflow Injection System for orthopedic cement gains FDA clearance
RTI Surgical's EVP of Administration Thomas Rose to retire: 3 quick facts
EOS imaging's hipEOS receives FDA approval

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers